Sparks were indeed flying at the BioSpark pitch event recently held at CvilleBioHub. SalivIQ, a former participant in Activation Capital’s pre-accelerator program Start-the Journey, presented their Strep A diagnostic test. Strep A is the only saliva-based test for strep throat infections, eliminating the need for follow-up throat cultures and allowing for antibiotics to be prescribed appropriately.
“We were honored to be recognized at BioSpark, and the exposure has led to new connections and momentum forward as we move closer to launching our product,” said Julia Halterman, Founder and CEO of SalivIQ Diagnostics, Inc. “We’re especially thankful for the early support from Activation Capital and the Start-the-Journey program, which played a key role in helping us get here.”
SalivIQ captured the runner-up prize of $5,000. To learn more about SalivIQ and their work, please visit https://www.saliviqdiagnostics.com/